An artificial organ is a human made organ device or tissue that is implanted or integrated into a human ﾗ interfacing with living tissue ﾗ to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently-abled person. LPI (LP Information)' newest research report, the ﾓArtificial Organs and Bionics Industry Forecastﾔ looks at past sales and reviews total world Artificial Organs and Bionics sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Organs and Bionics sales for 2023 through 2029. With Artificial Organs and Bionics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Organs and Bionics industry. This Insight Report provides a comprehensive analysis of the global Artificial Organs and Bionics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Organs and Bionics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firmsﾒ unique position in an accelerating global Artificial Organs and Bionics market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Organs and Bionics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Organs and Bionics. The global Artificial Organs and Bionics market size is projected to grow from US$ 8944.1 million in 2022 to US$ 15000 million in 2029; it is expected to grow at a CAGR of 7.7% from 2023 to 2029. North America is the largest market of Artificial Organs And Bionic Implants, with a share about 45%, followed by Europe and China, both have a share about 50 percent. Global top 5 companies include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT and Baxter, they hold a share over 50%. This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Organs and Bionics market by product type, application, key players and key regions and countries. Market Segmentation: Segmentation by type Artificial Kidney Artificial Heart & Ventricular Assist Device Cochlear Implant Artificial Lung Artificial Liver Artificial Pancreas Bionic Hands & Prosthetics Others Segmentation by application Commercialize Clinical Research This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Fresenius Medical Care Cochlear Abiomed ABBOTT Baxter B.Braun Asahi Kasei Corporation Nipro MED-EL Toray Medical Sonova Medtronic Getinge (Maquet) William Demant LivaNova (Sorin) Terumo Hangzhou Nurotron Syncardia CorWave Listent Medical Evaheart Open Bionics OYMotion Technologies Mobius Bionics
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Artificial Organs and Bionics Market Size 2018-2029
